Experimental study shows efficient RhB degradation with a novel photocatalyst, highlighting structural stability and reusability.
To efficiently degrade Rhodamine B (RhB), an MIL/BWO photocatalyst was prepared using a hydrothermal-solvothermal method. Its morphological structure and chemical composition were characterized and analyzed by SEM, XRD, FTIR, and XPS. The performance of MIL/BWO in activating peroxymonosulfate (PMS) for RhB degradation under visible light was also investigated. Under optimal reaction conditions—pH 3.29, PMS dosage of 4.11 mmol/L, MIL/BWO dosage of 1.59 g/L, stirring speed of 300 rpm, and reaction time of 60 min—the color and COD removal rates of an RhB aqueous solution (initial color 736 times and COD 134 mg/L) reached 92.47% and 71.19%, respectively. Furthermore, after five reuse cycles, MIL/BWO maintained color and COD removal rates of 85.28% and 63.35%, respectively, demonstrating excellent structural stability and reusability. This study presents a novel strategy for the efficient and stable degradation of RhB, with significant potential for practical applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: